Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States

04/03/2023
By Centers for Disease Control and Prevention (U.S.)

[PDF-180.49 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

CS321571-W

summary-interim-clinical-considerations.pdf
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Pandemics Vaccination
Document Type:

Pamphlet (or booklet)
Name as Subject:

Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine

Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine Less -
Genre:

Fact Sheet
Place as Subject:

United States
Pages in Document:

6 numbered papages
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:63d5b751715cbcc72b72d8343c840cf660a7e14be76079e39020f764b6e6724a
Download URL:

https://stacks.cdc.gov/view/cdc/127262/cdc_127262_DS1.pdf
File Type:

No Additional Files

More +

Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States

Details:

Supporting Files

You May Also Like